Cite
Human recombinant vascular endothelial growth factor reduces necrosis and enhances hepatocyte regeneration in a mouse model of acetaminophen toxicity.
MLA
Donahower, Brian C., et al. “Human Recombinant Vascular Endothelial Growth Factor Reduces Necrosis and Enhances Hepatocyte Regeneration in a Mouse Model of Acetaminophen Toxicity.” The Journal of Pharmacology and Experimental Therapeutics, vol. 334, no. 1, July 2010, pp. 33–43. EBSCOhost, https://doi.org/10.1124/jpet.109.163840.
APA
Donahower, B. C., McCullough, S. S., Hennings, L., Simpson, P. M., Stowe, C. D., Saad, A. G., Kurten, R. C., Hinson, J. A., & James, L. P. (2010). Human recombinant vascular endothelial growth factor reduces necrosis and enhances hepatocyte regeneration in a mouse model of acetaminophen toxicity. The Journal of Pharmacology and Experimental Therapeutics, 334(1), 33–43. https://doi.org/10.1124/jpet.109.163840
Chicago
Donahower, Brian C, Sandra S McCullough, Leah Hennings, Pippa M Simpson, Cindy D Stowe, Ali G Saad, Richard C Kurten, Jack A Hinson, and Laura P James. 2010. “Human Recombinant Vascular Endothelial Growth Factor Reduces Necrosis and Enhances Hepatocyte Regeneration in a Mouse Model of Acetaminophen Toxicity.” The Journal of Pharmacology and Experimental Therapeutics 334 (1): 33–43. doi:10.1124/jpet.109.163840.